![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » GENERIC-DRUG-MAKER ADMITS TO 'SIDE AGREEMENTS'
GENERIC-DRUG-MAKER ADMITS TO 'SIDE AGREEMENTS'
August 18, 2006
Apotex Inc., the generic-drug company that is selling a low-cost version of the blood thinner Plavix, admitted in court papers that it struck a "side agreement" with Bristol-Myers Squibb Co. and Sanofi-Aventis.
The Philadelphia Inquirer (http://www.philly.com/mld/inquirer/business/15302250.htm)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct